Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Sanofi delayed drug to avoid $708 million in payments, lawsuit claims

Tuesday, November 10, 2015

A new lawsuit accuses Sanofi SA of stalling development of its multiple sclerosis drug Lemtrada to avoid paying out at least million to rights holders under its agreement to acquire Genzyme Corp The lawsuit filed on Monday in Manhattan federal cou...

Lilly diabetes drug cuts heart failure death, hospitalization

Tuesday, November 10, 2015

Eli Lillys new diabetes drug Jardiance significantly cut the risk of heartrelated death and hospitalization for heart failure in patients with type diabetes who are at high risk for serious heart problems according to data from a large study present...

Nicox and Fera Pharmaceuticals sign exclusive license agreement for naproxcinod in the U.S.

Tuesday, November 10, 2015

Nicox SA the international ophthalmic company and Fera Pharmaceuticals a privatelyheld specialty pharmaceutical company announced today that they have entered into an exclusive license agreement for the development and commercialization of Nicoxs nap...

Hanmi Pharmaceutical bags US$915 mln license deal with Janssen

Monday, November 09, 2015

South Korean pharmaceutical company Hanmi Pharmaceutical Co said Monday that it has reached a license agreement with global drugmaker Janssen to develop a new diabetesobesity drug valued at US million Under the agreement Hanmi will receive an upfron...

Novo Nordisk diabetes drug fails to help heart failure

Monday, November 09, 2015

The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure researchers reported at a medical meeting on Sunday The injectable drug known chemically as liraglutide was...

Cytokinetics, Amgen drug shows promise in heart failure

Monday, November 09, 2015

An experimental heart failure drug being developed by Cytokinetics Inc and Amgen Inc demonstrated several beneficial cardiac function effects in a midstage clinical trial according to data presented on Sunday The trial of patients with chronic hear...

Medicines Patent Pool (MPP) expands mandate to Hepatitis C and Tuberculosis Treatment

Saturday, November 07, 2015

The Medicines Patent Pool MPP the worlds only voluntary licensing mechanism in public health announced an expansion of its mandate today to hepatitis C and tuberculosis medicines The UNITAID Executive Board meeting November in Geneva approved the MP...

Crossject secures 6.7 million euros in funding for the development of three new drugs

Friday, November 06, 2015

Crossject secures million euros million in funding for the development of three new drugs Announces that it has been awarded by Bpifrance a refundable grant of million euros over three years as part of industrial projects of future projets indust...

EU regulator finds no safety issues with GSK, Merck HPV vaccines

Friday, November 06, 2015

European drug regulators have found no safety concerns linking GlaxoSmithKlines and Mercks cervical cancer vaccines with two conditions known as complex regional pain syndrome CRPS and postural orthostatic tachycardia syndrome POTS Concluding a safe...

PharMerica acquires Luker Pharmacy Management

Friday, November 06, 2015

PharMerica Corporation PMC a diversified national provider of institutional and specialty pharmacy services announced today that it has completed the acquisition of Luker Pharmacy Management Luker Terms of the transaction were not disclosed Luker pr...